Saratoga Investment Corp 8.00%
Saratoga Investment Corp 8.00% Q3 FY2025 earnings call
January 9, 2025 · fiscal period ended 2024-11
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-01-09
Management highlights
- Adjusted NII had changes due to factors like nonrecurring Knowland interest reserve reversal, SOFR base rate decreases, and higher yields from repayments. - NAV had increases and changes in NAV per share. - Originations included new and follow-on investments. - Portfolio companies are generally healthy with some nonaccrual investments that have been restructured. - Management is focused on deploying capital, maintaining relationships, and managing the portfolio through credit cycles.
Segment performance
In the fiscal third quarter ended November 30, 2024, adjusted NII was $12.4 million, down 5.3% from last year and 31.7% from last quarter. Adjusted NII per share was $0.90, down 10.9% from last year and 32.3% from last quarter. Excluding the nonrecurring Knowland interest reserve reversal, adjusted NII per share increased $0.01 per share. NAV per share was $26.95, down 1.7% from last year and 0.4% from last quarter. NAV was $374.9 million, up from $359.6 million last year and $372.1 million last quarter. Originations were elevated with $85 million in 2 new portfolio company investments and 8 follow-on investments in existing portfolio companies. Quarter end cash position grew to $250 million due to outsized repayments. The core non-CLO portfolio was 3% above cost, while the CLO and JV were marked down by $4 million. The portfolio fair value was 0.7% below cost.
Guidance
- Management is confident in the ability to achieve healthy portfolio growth despite market challenges. - Expectations regarding origination and repayment paces are not precisely predictable, but they believe in the long-term potential. - Evaluate the use of call options on debt to reduce current debt based on interest rate and cash position. - Anticipate potential resurgence in M&A activity in the lower middle market which could impact future growth.
Risks
- Uncertainty in M&A volumes and interest rate levels affecting investment opportunities. - Potential for continued credit challenges in some portfolio companies. - Impact of outsized repayments not fully reflected in current results yet. - Volatility in equity marks compared to debt marks in the portfolio.
Q&A highlights
Q: About the pace of repayments and future expectations, A: Repayments are lumpy, hard to predict precisely, but management is confident in long-term origination outpacing repayments with relationships and business development.
Q: About SBIC debentures and calling them, A: Decision to call or not depends on reinvestment period, cash needs for follow-ons, and arbitrage assessment.
Q: About realizing equity gains, A: Typically realize returns when companies are sold, as minority investors, but thorough work on businesses helps assess equity co-investment opportunities.
Q: About refinancing risk, A: Hard to predict, but no high vulnerability seen currently, expecting M&A activity to pick up origination pace.
Q: About spillover taxable income and special dividends, A: Spillover taxable income is in current tax year, excise tax is a factor, and Board considers financing costs and origination pace in decisions.
Q: About marks in consumer-related businesses, A: Modest write-downs in some consumer-facing investments are specific to those businesses' dynamics, not broader macro trends.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
January 9, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.